NCT05505565

Brief Summary

We are evaluating whether intermittent use of continuous glucose monitors (CGMs) in addition to standard nutritional counseling and physical activity counseling is associated with improved metabolic health for youth with pre-diabetes (PD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 15, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 17, 2022

Completed
10 months until next milestone

Study Start

First participant enrolled

June 5, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2025

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

June 17, 2026

Completed
Last Updated

June 17, 2026

Status Verified

August 1, 2025

Enrollment Period

1.9 years

First QC Date

August 15, 2022

Results QC Date

April 7, 2026

Last Update Submit

May 20, 2026

Conditions

Keywords

pediatricsprediabetesobesity

Outcome Measures

Primary Outcomes (2)

  • CGM Acceptability

    Caregiver and patient acceptability of CGM use

    6 months

  • Change in Measured % HbA1c From Baseline to 6-months

    The difference in measured percentage of glycosylated hemoglobin (hemoglobin A1c) was obtained by subtracting the 6-month value from the baseline value for all subjects with paired data available. A negative result indicates a reduction (improvement) in hemoglobin A1c over the period.

    6 months

Secondary Outcomes (4)

  • Change in HOMA-IR From Baseline to 6-months.

    6 months

  • Change in Triglyceride, HDL, LDL, and Total Cholesterol From Baseline to 6-month

    6 months

  • Changes in Liver Enzymes From Baseline to 6-months.

    6 months

  • Glycemic Metrics

    6 months

Study Arms (3)

CGM + Traditional Counseling

EXPERIMENTAL

Subjects in this arm will receive intermittent CGM to be used for 2-weeks each month for the 6-month study period. They will be required to wear a CGM during baseline, 3-month, and 6-month periods. Additional CGM sensors will be supplied for months 1, 2, 4, and 5 and will be optional. They will be provided with a Sworkit(R) account to monitor physical activity completed through the Sworkit(R) website/platform.

Device: Abbott Freestyle Libre 2Other: Standard physical activity and nutritional counseling for prediabetes management

Control

ACTIVE COMPARATOR

Subjects in this arm will receive standard medical care for pre-diabetes. They will be provided with a Sworkit(R) account to monitor physical activity completed through the Sworkit(R) website/platform.

Other: Standard physical activity and nutritional counseling for prediabetes management

Caregivers of CGM + Traditional Counseling Group

NO INTERVENTION

Caregivers of those randomized to the intervention group were enrolled to give their feedback on the continuous glucose monitor via surveys at the 3-month and 6-month visits. Outside these surveys, there were no other inputs or interventions to this group.

Interventions

Subjects will be educated on use of Abbott Freestyle Libre 2 and educated on how daily activities impact glucose.

CGM + Traditional Counseling

Subjects will be advised on recommendations for nutrition and activity goals for preventing progression of prediabetes.

CGM + Traditional CounselingControl

Eligibility Criteria

Age11 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age 11 or older
  • English-speaking
  • stable metformin dose for 1 month prior to enrollment or no metformin use
  • baseline A1c of 5.7-6.4%
  • BMI \> = 85% for age

You may not qualify if:

  • BMI \< 85% for age
  • chronic steroid use
  • diagnosis of type 1 diabetes, type 2 diabetes, other forms of diabetes
  • current or history of malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's of Alabama

Birmingham, Alabama, 35233, United States

Location

MeSH Terms

Conditions

Prediabetic StateObesityInsulin Resistance

Interventions

Nutrition Assessment

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHyperinsulinism

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Limitations and Caveats

CGM data is limited due to the number of participants with data available at baseline and 6-month follow-up. While fasting labs were requested, participants were not supervised for the 8-hours prior to their study visits, so confounding by non-fasting is possible.

Results Point of Contact

Title
Jessica Schmitt
Organization
University of Alabama at Birmingham

Study Officials

  • Jessica A Schmitt, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized, non-blinded, parallel, intervention vs control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 15, 2022

First Posted

August 17, 2022

Study Start

June 5, 2023

Primary Completion

May 15, 2025

Study Completion

May 15, 2025

Last Updated

June 17, 2026

Results First Posted

June 17, 2026

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations